Target intelligence / Profile preview

Cytokine networks

Molecular classification
Other (complex network of cytokines including interleukins, interferons, tumor necrosis factors, chemokines, and their receptors; not a single molecular entity)
01

Overview

Cytokine networks form a dense, interconnected web of signaling proteins secreted by immune cells like macrophages, T cells, and dendritic cells, as well as non-immune body cells such as fibroblasts and endothelial cells, enabling coordinated responses to infection, injury, and antigens. This architecture, characterized by high connectivity density (e.g., 0.61 for immune sub-networks), organizes innate and adaptive immunity through motifs like cliques and tiers, where cells like macrophages and B cells act as central hubs. Cytokines, including interleukins (e.g., IL-1 to IL-27), interferons, TNF family members, and chemokines, bind shared receptor families (e.g., four-helix bundle, TNF receptors), leading to pleiotropy (one cytokine with multiple effects) and redundancy (overlapping functions). In disease, dysregulated networks drive chronic inflammation in autoimmunity, cytokine storms in severe infections like COVID-19, and tumor progression in cancer. Therapeutically, drugs indirectly target network nodes—such as anti-TNF biologics for rheumatoid arthritis or JAK inhibitors for cytokine signaling—but holistic network modulation remains challenging due to complexity and feedback loops.

Other names
Cytokine signaling networkimmune cytokine networkcytokine communication platform
02

Biological functions

Immune responseInflammationSignal transductionCell proliferationCell differentiationHematopoiesisTissue repair
03

Disease associations

InflammationInfectionCancerAutoimmunityOther (e.g., cardiovascular disease, wound healing dysregulation)
04

Safety considerations

Cytokine release syndrome (overactivation leading to systemic inflammation)Immunosuppression (increased infection risk from blockade)Autoimmunity dysregulationPleiotropy and redundancy causing off-target effects

Beyond the preview

Go deeper on Cytokine networks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokine networks.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call